Therametrics Discovery AG
Records under this name other than patents Therametrics Discovery AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Therametrics Discovery AG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,178,489 | Formulation for aviptadil Formerly held In force (reinstated) · USPTO record | In force (reinstated) | USPTO record | |
| US 8,153,599 | Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension Formerly held Term ended Term ended Sep 5, 2024 · USPTO record | Term ended | Term ended Sep 5, 2024 | USPTO record |
| US 8,541,364 | Use of a octreotide as a therapeutic agent Lapsed on the fee record Ended Sep 24, 2017 · USPTO record | Lapsed on the fee record | Ended Sep 24, 2017 | USPTO record |
| US 8,349,805 | Use of Gonadorelin as a therapeutic agent Lapsed on the fee record Ended Jan 8, 2017 · USPTO record | Lapsed on the fee record | Ended Jan 8, 2017 | USPTO record |
| US 8,338,380 | Use of the peptide RFMWMR as a therapeutic agent Lapsed on the fee record Ended Dec 25, 2016 · USPTO record | Lapsed on the fee record | Ended Dec 25, 2016 | USPTO record |
| US 8,211,856 | Use of somatostatin-14 as a therapeutic agent Lapsed on the fee record Ended Jul 3, 2016 · USPTO record | Lapsed on the fee record | Ended Jul 3, 2016 | USPTO record |
| US 8,193,149 | Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicine Lapsed on the fee record Ended Jun 5, 2016 · USPTO record | Lapsed on the fee record | Ended Jun 5, 2016 | USPTO record |
| US 7,951,778 | Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis Lapsed on the fee record Ended May 31, 2015 · USPTO record | Lapsed on the fee record | Ended May 31, 2015 | USPTO record |